Late adverse effects of childhood acute lymphoblastic leukemia treatment on developing dentition

被引:8
|
作者
Immonen, Egle [1 ,2 ]
Nikkila, Atte [1 ,3 ,4 ]
Peltomaki, Timo [2 ,5 ,6 ]
Aine, Liisa [2 ,5 ]
Lohi, Olli [1 ,3 ,4 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Tampere Ctr Child Adolescent & Maternal Hlth Res, Tampere, Finland
[2] Tampere Univ Hosp, Dept Ear & Oral Dis, Tampere, Finland
[3] Tampere Univ, Tays Canc Ctr, Tampere, Finland
[4] Tampere Univ Hosp, Tampere, Finland
[5] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[6] Univ Eastern Finland, Inst Dent, Kuopio, Finland
关键词
defect; dentition; development; leukemia; survivor; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; DENTAL ANOMALIES; RISK-FACTORS; ORAL-HEALTH; CHILDREN; CANCER; CHEMOTHERAPY; SURVIVORS; ABNORMALITIES;
D O I
10.1002/pbc.29200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Childhood cancer survivors show a variety of late adverse effects on dental health. The purpose of this study was to examine the prevalence and severity of dental abnormalities in permanent dentition in childhood leukemia survivors. Materials and methods Retrospective analysis of panoramic radiographs was performed for 178 childhood leukemia survivors aged below 17 years at the time of diagnosis. Sex, age at diagnosis, interval between ALL diagnosis and the follow-up radiograph, treatment protocol, and risk grouping were recorded. Abnormalities of tooth development and defect index were used to assess the frequency and severity of dental abnormalities. Results One hundred eight (61%) patients had no dental abnormalities at follow-up examination at a median of 6.1 years after diagnosis. Microdontia was more frequent in children under 6 years of age at the time of diagnosis (5.7% vs. 0.6%, p < .001). Significant differences were noted between distinct ALL treatment protocols with more common microdontia in patients treated according to the NOPHO ALL2008 protocol. Tooth agenesis was more frequent in patients that underwent therapy according to high-risk arms compared to intermediate- or standard-risk arms (3.8% vs. 1.4%, p = .01). Patients under 6 years of age at diagnosis had a significantly higher average defect index score than older patients (7.0 vs. 2.8, p = .01). Conclusions Children and adolescents who received ALL treatment were at risk for dental damage. Young age and high-intensity therapy were associated with the severity of dental abnormalities.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Assessment of Obesity and Hepatic Late Adverse Effects in the Egyptian Survivors of Pediatric Acute Lymphoblastic Leukemia: a Single Center Study
    El-Rashedy, Farida H.
    El-Hawy, Mahmoud A.
    El Hefnawy, Sally M.
    Mohammed, Mona M.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [22] The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results
    Antillon, Federico G.
    Blanco, Jessica G.
    Valverde, Patricia D.
    Castellanos, Mauricio
    Garrido, Claudia P.
    Giron, Veronica
    Letona, Tomas R.
    Osorio, Emilia J.
    Borrayo, Dyna A.
    Mack, Ricardo A.
    Melgar, Mario A.
    Lorenzana, Rodolfo
    Ribeiro, Raul C.
    Metzger, Monika
    Conter, Valentino
    Rossi, Emanuela
    Valsecchi, Maria Grazia
    CANCER, 2017, 123 (03) : 436 - 448
  • [23] Outcome of Childhood Acute Lymphoblastic Leukemia in Jordan
    Halalsheh, Hadeel
    Abuirmeileh, Najyah
    Rihani, Rawad
    Bazzeh, Faiha
    Zaru, Luna
    Madanat, Faris
    PEDIATRIC BLOOD & CANCER, 2011, 57 (03) : 385 - 391
  • [24] Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia
    Rathe, Mathias
    Carlsen, Niels L. T.
    Oxhoj, Henrik
    PEDIATRIC BLOOD & CANCER, 2007, 48 (07) : 663 - 667
  • [25] Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
    Malczewska, Marta
    Kosmider, Kamil
    Bednarz, Kinga
    Ostapinska, Katarzyna
    Lejman, Monika
    Zawitkowska, Joanna
    CANCERS, 2022, 14 (08)
  • [26] Effects of Race/Ethnicity and Socioeconomic Status on Outcome in Childhood Acute Lymphoblastic Leukemia
    Acharya, Sahaja
    Hsieh, Samantha
    Shinohara, Eric T.
    DeWees, Todd
    Frangoul, Haydar
    Perkins, Stephanie M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (05) : 350 - 354
  • [27] New and traditional directions in the biology and management of childhood acute lymphoblastic leukemia
    Egyed Balint
    Kovacs Gabor
    Kutszegi Nora
    Rzepiel Andrea
    Csanyine Sagi Judit
    Erdelyi Daniel Janos
    Mueller Judit
    Felne Semsei Agnes
    ORVOSI HETILAP, 2018, 159 (20) : 786 - 797
  • [28] Risk Factors for Relapse of Childhood B Cell Acute Lymphoblastic Leukemia
    Zhang, Rongrong
    Zhu, Haiyan
    Yuan, Yufang
    Zhao, Jiou
    Yang, Xiaochun
    Tian, Zhaofang
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [29] Acute lymphoblastic leukemia in young adults: which treatment?
    Anandappa, Annabelle
    Curran, Emily
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2023, (01) : 587 - 592
  • [30] Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia
    Levinsen, Mette
    Taskinen, Mervi
    Abrahamsson, Jonas
    Forestier, Erik
    Frandsen, Thomas L.
    Harila-Saari, Arja
    Heyman, Mats
    Jonsson, Olafur G.
    Lahteenmaki, Paeivi M.
    Lausen, Birgitte
    Vaitkeviciene, Goda
    Asberg, Ann
    Schmiegelow, Kjeld
    PEDIATRIC BLOOD & CANCER, 2014, 61 (08) : 1416 - 1421